The Food and Drug Administration on Monday amended the emergency use authorization for the Pfizer-BioNTech coronavirus vaccine to expand eligibility for booster doses to individuals ages 12 to 15.
Black News, Commentary and Culture | The Washington Informer
The Food and Drug Administration on Monday amended the emergency use authorization for the Pfizer-BioNTech coronavirus vaccine to expand eligibility for booster doses to individuals ages 12 to 15.
